Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Udaya Valluri
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study
Journal of the American Academy of Dermatology
Dermatology
Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study
British Journal of Dermatology
Dermatology
Medicine
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
SKIN The Journal of Cutaneous Medicine
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis
Journal of Dermatological Treatment
Dermatology
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients With Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
